CStone granted the exclusive rights to Hengrui for research, development, registration, manufacturing, and commercialization of anti-CTLA-4 mAb CS1002 in the Greater China region
The company is continuing with the evaluation of canakinumab in lung cancer, and is applying findings to the overall lung cancer development plan
Abiraterone by Dr Reddy's becomes the first anti-cancer drug from India to enter the Chinese market
Lenalidomide is used to treat cancer and also some anaemia disorders
Osimertinib works by slowing or stopping the growth of cancer cells and binds to a certain protein (epidermal growth factor receptor-EGFR) in some tumors
Prostate cancer is one of the fastest-growing cancers in India, with approximately 37,948 new cases each year
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
The privately held biotech brings a first-in-class oncology program focused on small molecule–targeted protein degradation
The drug, currently in a phase 1b/2 clinical trial for small cell lung cancer, is a polymer nanoparticle formulation of SN-38
Subscribe To Our Newsletter & Stay Updated
